Sodium monofluorophosphate increases vertebral bone mineral density in patients with corticosteroid-induced osteoporosis

Osteoporosis International

Volumn 5, Issue 1, 1995, Pages 39-46

  Rizzoli, R ^a   Chevalley, T ^a   Slosman, D O ^a   Bonjour, J P ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Bone mineral density; Calcium; Corticosteroid; Fluoride; Osteoporosis

Indexed keywords

CALCIUM; CORTICOSTEROID; FLUOROPHOSPHATE; INORGANIC SALT; PREDNISONE;

ADULT; ARTICLE; BONE DENSITY; BONE MINERAL; BONE REMODELING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DOUBLE BLIND PROCEDURE; FEMALE; FEMUR NECK; FEMUR SHAFT; GASTROINTESTINAL SYMPTOM; HUMAN; LUMBAR SPINE; MALE; OSTEOPOROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; TRABECULAR BONE;

ADRENAL CORTEX HORMONES; AGED; BONE DENSITY; FEMALE; FEMUR; FLUORIDES; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; PHOSPHATES; SPINE;

EID: 0028894180     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/BF01623657     Document Type: Article

References (29)

1. Pathogenesis and treatment of steroid osteoporosis
2. Glucocorticoid-induced osteoporosis: pathogenesis and management
3. Unpredictable deleterious effects of long term glucocorticoid therapy on lumbar spine and femoral neck bone mineral density
4. Corticosteroid effects on proximal femur bone loss
5. Bone histomorphometry in corticosteroid-induced osteoporosis and Cushing's syndrome
6. Bone histomorphometry in glucocorticoid-induced osteoporosis
7. Low serum osteocalcin levels in glucocorticoid-treated asthmatics
8. The course of biochemical parameters of bone turnover during treatment with corticosteroids
9. Relationship of glucocorticoid dosage to serum bone Gla-protein concentration in patients with rheumatologic disorders
10. Malabsorption of calcium in corticosteroid-induced osteoporosis
11. Fluoride therapy for the vertebral crush fracture syndrome: a status report
12. Fluoride therapy for osteoporosis: a review of dose response, duration of treatment, and skeletal sites of action
13. Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis
14. Fluoride therapy for vertebral osteoporosis
15. The long term treatment of steroid osteoporosis with fluoride
16. Treatment with fluoride: bone histomorphometric findings
17. Bone loss after cardiac transplantation: effects of calcium, calcidiol and monofluorophosphate
18. Corticosteroid-induced osteoporosis: effects of a treatment with slow-release sodium fluoride
19. Comparative study of the performance of X-ray and gadolinium-153 bone densitometers at the level of spine, femoral neck and femoral shaft
20. Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone disease
21. Bone and renal components in hypercalcemia of malignancy and responses to a single infusion of clodronate
22. The assessment of phosphate reabsorption
23. Densité minérale osseuse de la colonne lombaire, du col et de la diaphyse f émoraux d'un ećhantillon de la population genevoise
24. Bone loss in response to long-term glucocorticoid therapy
25. Treatment of vertebral osteoporosis with disodium monofluorophosphate: comparison with sodium fluoride
26. Fluoride therapy in postmenopausal osteopenic women: effect on vertebral and femoral bone density and prediction of bone response
27. Vitamin D3 and calcium to prevent hip fractures in elderly women
28. Calcium supplements in the prevention of steroid-induced osteoporosis